Inicio › Artritis psoriásica › Texas

Ensayos clínicos de Artritis psoriásica en Texas

17 estudios sobre Artritis psoriásica buscan participantes en Texas.

Ciudades en Texas

Texto oficial del estudio (inglés)

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Arthritis and Rheumatology Research Institute, Frisco

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07321873

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

Precision Comprehensive Research, Colleyville
Rheumatology Associates of South Texas, San Antonio

ReclutandoFase 2

Edades de 18 a 100 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07801495

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

UT Southwestern, Dallas
Arthritis and Rheumatology Research Institute, Frisco
AARA Clinical Research Lone Star Arthritis and Rheumatology, Irving
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06807424

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Cook Childrens Medical Center, Fort Worth

ReclutandoFase 3

Edades de 3 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06663332

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Accurate Clinical Research, Baytown
Novel Research | Bellaire Location, Bellaire
Novel Research | Bellaire Location, Bellaire
y 5 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06671483

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Greater Houston Rheumatology ( Site 5103), Houston

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07486960

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Clinical Site, Austin
Clinical Site, Baytown
Clinical Site, Colleyville
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06641089

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

AARR- Lone Star Arthritis & Rheumatology Associates, Fort Worth
Biopharma Informatic | Hassan, Houston
Advanced Rheumatology of Houston - The Woodlands, The Woodlands

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06671496

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Accurate Clinical Research, Baytown
Novel Research LLC, Bellaire
Novel Research | Abigail Neiman - Houston, TX, Houston
y 4 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07286058

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Child Neurology Consultants of Austin /ID# 260562, Austin

ReclutandoFase 3

Edades de 5 a 17 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06100744

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

UT Southwestern Medical Center, Dallas

ReclutandoFase 4

Edades de 18 a 65 · Todos los sexos · Actualizado el 1 sept 2026 · NCT07280702

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

University of Texas Southwestern Medical Center Dallas, Dallas
Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston

ReclutandoEstudio observacional

Hasta los 21 · Todos los sexos · Actualizado el 27 ago 2026 · NCT02418442

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Pa0019 129, Baytown
Pa0019 136, Colleyville
Pa0019 135, Mesquite
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT07290036

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 may 2026 · NCT04751396

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

Tekton Research - West Gate /ID# 272765, Austin
Accurate Clinical Research - Houston /ID# 272754, Houston
Tekton Research, LLC /ID# 272901, San Antonio
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 dic 2025 · NCT06865105

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Heritage Rheumatology and Arthritis Care, Colleyville
Texas Arthritis Center, El Paso

ReclutandoFase 3

Edades de 18 a 80 · Todos los sexos · Actualizado el 9 oct 2025 · NCT05669833

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.